Apollo Medical(AMEH)
Search documents
Apollo Medical(AMEH) - 2023 Q2 - Earnings Call Transcript
2023-08-08 04:00
Apollo Medical Holdings Inc. (NASDAQ:AMEH) Q2 2023 Earnings Conference Call August 7, 2023 5:30 PM ET Company Participants Carolyne Sohn - Vice President of Investor Relations Brandon Sim - Co-Chief Executive Officer Chan Basho - Chief Financial Officer Conference Call Participants Jack Senft - William Blair Adam Ron - Bank of America Brooks O'Neil - Lake Street Capital Markets Operator Hello and welcome to the Apollo Medical Holdings' Second Quarter 2023 Financial Results Conference Call and Webcast. [Oper ...
Apollo Medical(AMEH) - 2023 Q1 - Quarterly Report
2023-05-09 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of Each Class Trading Symbol Name of Each Exchange on Which Registered Common Stock, $0.001 par value per share AMEH Nasdaq Capital Market FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ to ___. Commission File ...
Apollo Medical(AMEH) - 2023 Q1 - Earnings Call Transcript
2023-05-09 04:16
Apollo Medical Holdings Inc. (NASDAQ:AMEH) Q1 2023 Earnings Conference Call May 8, 2023 5:30 PM ET Company Participants Carolyne Sohn - VP of IR Brandon Sim - Co-CEO Chan Basho - Chief Financial Officer Conference Call Participants Ryan Daniels - William Blair Brooks O'Neil - Lake Street Capital Markets Adam Ron - Bank of America Operator Greetings. Welcome to Apollo Medical Holdings First Quarter 2023 Financial Results. At this time, all participants are in a listen-only mode. A question and answer session ...
Apollo Medical(AMEH) - 2022 Q4 - Annual Report
2023-02-28 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from ___ to ___ . Commission file number: 001-37392 Apollo Medical Holdings, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of i ...